| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
548,324 |
Avg
Vol: |
491,730 |
| 52
Week Range: |
$71.24 - $93.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
22,518 |
91,806 |
| Total Sell Value |
$0 |
$0 |
$1,982,727 |
$7,138,305 |
| Total People Sold |
0 |
0 |
4 |
9 |
| Total Sell Transactions |
0 |
0 |
6 |
33 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$22,642 |
D/D |
(411) |
34,774 |
|
-24% |
|
| Simon Christopher |
President & CEO |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$149,569 |
D/D |
(2,715) |
193,006 |
|
-24% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,753 |
4,174 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2021-05-26 |
4 |
S |
$55.10 |
$650,896 |
D/D |
(11,813) |
18,440 |
|
-27% |
|
| Kroll Mark W |
Director |
• • – |
2021-05-26 |
4 |
OE |
$35.50 |
$367,557 |
D/D |
10,353 |
30,253 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$6,181 |
D/D |
(112) |
4,411 |
|
-23% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$13,135 |
D/D |
(238) |
35,185 |
|
-23% |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$6,899 |
D/D |
(125) |
14,620 |
|
-23% |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$5,077 |
D/D |
(92) |
14,202 |
|
-23% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$12,142 |
D/D |
(220) |
39,047 |
|
-23% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$2,318 |
D/D |
(42) |
2,421 |
|
-23% |
|
| Simon Christopher |
President & CEO |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$56,515 |
D/D |
(1,024) |
195,721 |
|
-23% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
24,305 |
35,423 |
|
- |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,605 |
14,745 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,605 |
14,294 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
23,864 |
39,267 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
994 |
2,463 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,515 |
196,745 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$2,351 |
D/D |
(42) |
1,469 |
|
-22% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$11,418 |
D/D |
(204) |
15,403 |
|
-22% |
|
| Simon Christopher |
President & CEO |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$53,507 |
D/D |
(956) |
170,230 |
|
-22% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$12,257 |
D/D |
(219) |
11,118 |
|
-22% |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$5,709 |
D/D |
(102) |
4,523 |
|
-22% |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$6,381 |
D/D |
(114) |
4,140 |
|
-22% |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2021-04-16 |
4 |
S |
$119.44 |
$20,305 |
D/D |
(170) |
3,444 |
|
49% |
|
1310 Records found
|
|
Page 6 of 53 |
|
|
0.45 (0.49%) 
